The Experts below are selected from a list of 21639 Experts worldwide ranked by ideXlab platform

Nadine A Kasparian - One of the best experts on this subject based on the ideXlab platform.

  • parents perceptions of power wheelchair prescription for children with a Neuromuscular Disorder a scoping review
    Disability and Rehabilitation, 2019
    Co-Authors: Sarahgrace Paguinto, Nadine A Kasparian, Paula Bray, Michelle A Farrar
    Abstract:

    Purpose: To conduct a scoping review of the published evidence on parents' perceptions of power wheelchair prescription for children with a Neuromuscular Disorder and clinicians' influence on timely wheelchair implementation.Method: Nine electronic databases and reference lists of all retrieved full-text articles were searched up to March 2017. Eligibility criteria included (1) at least one child participant with a Neuromuscular Disorder, (2) power wheelchair as an intervention, and (3) qualitative, quantitative or mixed methods parent-reported outcomes related to power wheelchair equipment.Results: None of the 67 eligible studies examined parental perceptions of wheelchair prescription as a primary aim, and only 10 studies included children with a Neuromuscular Disorder. Parents reported their own emotional responses including grief and loss, emphasis on their child's walking and lack of accessibility as key barriers to power wheelchair prescription. Clinicians' perspectives on walking and powered mobility influenced parental decision-making regarding power wheelchair use for their child.Conclusion: Parents' experiences of initial wheelchair prescription have not been explored in existing literature. Clinicians' understanding of the benefits of power wheelchair equipment, particularly in the context of progression of Neuromuscular Disorders, is critical to facilitating timely wheelchair prescription with children. Condition-specific evidence is urgently needed to inform and support multidisciplinary management of children and their families.Implications for RehabilitationIt is important that rehabilitation professionals recognize parental barriers to initial power wheelchair prescription, such as strong emotional responses, an emphasis on their child's walking and lack of access.Clinicians' perspectives on walking and powered mobility may influence parental decision-making regarding engagement in power wheelchair prescription and rehabilitation.It is critical that clinicians are aware of and actively educate families regarding the benefits of powered mobility to facilitate timely prescription and support physical and psychological adjustment.

  • Parents’ perceptions of power wheelchair prescription for children with a Neuromuscular Disorder: a scoping review
    'Informa UK Limited', 2019
    Co-Authors: Sarahgrace Paguinto, Nadine A Kasparian, Bray P, Farrar M
    Abstract:

    © 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group. Purpose: To conduct a scoping review of the published evidence on parents’ perceptions of power wheelchair prescription for children with a Neuromuscular Disorder and clinicians’ influence on timely wheelchair implementation. Method: Nine electronic databases and reference lists of all retrieved full-text articles were searched up to March 2017. Eligibility criteria included (1) at least one child participant with a Neuromuscular Disorder, (2) power wheelchair as an intervention, and (3) qualitative, quantitative or mixed methods parent-reported outcomes related to power wheelchair equipment. Results: None of the 67 eligible studies examined parental perceptions of wheelchair prescription as a primary aim, and only 10 studies included children with a Neuromuscular Disorder. Parents reported their own emotional responses including grief and loss, emphasis on their child’s walking and lack of accessibility as key barriers to power wheelchair prescription. Clinicians’ perspectives on walking and powered mobility influenced parental decision-making regarding power wheelchair use for their child. Conclusion: Parents’ experiences of initial wheelchair prescription have not been explored in existing literature. Clinicians’ understanding of the benefits of power wheelchair equipment, particularly in the context of progression of Neuromuscular Disorders, is critical to facilitating timely wheelchair prescription with children. Condition-specific evidence is urgently needed to inform and support multidisciplinary management of children and their families.Implications for Rehabilitation It is important that rehabilitation professionals recognize parental barriers to initial power wheelchair prescription, such as strong emotional responses, an emphasis on their child’s walking and lack of access. Clinicians’ perspectives on walking and powered mobility may influence parental decision-making regarding engagement in power wheelchair prescription and rehabilitation. It is critical that clinicians are aware of and actively educate families regarding the benefits of powered mobility to facilitate timely prescription and support physical and psychological adjustment

Michelle A Farrar - One of the best experts on this subject based on the ideXlab platform.

  • parents perceptions of power wheelchair prescription for children with a Neuromuscular Disorder a scoping review
    Disability and Rehabilitation, 2019
    Co-Authors: Sarahgrace Paguinto, Nadine A Kasparian, Paula Bray, Michelle A Farrar
    Abstract:

    Purpose: To conduct a scoping review of the published evidence on parents' perceptions of power wheelchair prescription for children with a Neuromuscular Disorder and clinicians' influence on timely wheelchair implementation.Method: Nine electronic databases and reference lists of all retrieved full-text articles were searched up to March 2017. Eligibility criteria included (1) at least one child participant with a Neuromuscular Disorder, (2) power wheelchair as an intervention, and (3) qualitative, quantitative or mixed methods parent-reported outcomes related to power wheelchair equipment.Results: None of the 67 eligible studies examined parental perceptions of wheelchair prescription as a primary aim, and only 10 studies included children with a Neuromuscular Disorder. Parents reported their own emotional responses including grief and loss, emphasis on their child's walking and lack of accessibility as key barriers to power wheelchair prescription. Clinicians' perspectives on walking and powered mobility influenced parental decision-making regarding power wheelchair use for their child.Conclusion: Parents' experiences of initial wheelchair prescription have not been explored in existing literature. Clinicians' understanding of the benefits of power wheelchair equipment, particularly in the context of progression of Neuromuscular Disorders, is critical to facilitating timely wheelchair prescription with children. Condition-specific evidence is urgently needed to inform and support multidisciplinary management of children and their families.Implications for RehabilitationIt is important that rehabilitation professionals recognize parental barriers to initial power wheelchair prescription, such as strong emotional responses, an emphasis on their child's walking and lack of access.Clinicians' perspectives on walking and powered mobility may influence parental decision-making regarding engagement in power wheelchair prescription and rehabilitation.It is critical that clinicians are aware of and actively educate families regarding the benefits of powered mobility to facilitate timely prescription and support physical and psychological adjustment.

Sarahgrace Paguinto - One of the best experts on this subject based on the ideXlab platform.

  • parents perceptions of power wheelchair prescription for children with a Neuromuscular Disorder a scoping review
    Disability and Rehabilitation, 2019
    Co-Authors: Sarahgrace Paguinto, Nadine A Kasparian, Paula Bray, Michelle A Farrar
    Abstract:

    Purpose: To conduct a scoping review of the published evidence on parents' perceptions of power wheelchair prescription for children with a Neuromuscular Disorder and clinicians' influence on timely wheelchair implementation.Method: Nine electronic databases and reference lists of all retrieved full-text articles were searched up to March 2017. Eligibility criteria included (1) at least one child participant with a Neuromuscular Disorder, (2) power wheelchair as an intervention, and (3) qualitative, quantitative or mixed methods parent-reported outcomes related to power wheelchair equipment.Results: None of the 67 eligible studies examined parental perceptions of wheelchair prescription as a primary aim, and only 10 studies included children with a Neuromuscular Disorder. Parents reported their own emotional responses including grief and loss, emphasis on their child's walking and lack of accessibility as key barriers to power wheelchair prescription. Clinicians' perspectives on walking and powered mobility influenced parental decision-making regarding power wheelchair use for their child.Conclusion: Parents' experiences of initial wheelchair prescription have not been explored in existing literature. Clinicians' understanding of the benefits of power wheelchair equipment, particularly in the context of progression of Neuromuscular Disorders, is critical to facilitating timely wheelchair prescription with children. Condition-specific evidence is urgently needed to inform and support multidisciplinary management of children and their families.Implications for RehabilitationIt is important that rehabilitation professionals recognize parental barriers to initial power wheelchair prescription, such as strong emotional responses, an emphasis on their child's walking and lack of access.Clinicians' perspectives on walking and powered mobility may influence parental decision-making regarding engagement in power wheelchair prescription and rehabilitation.It is critical that clinicians are aware of and actively educate families regarding the benefits of powered mobility to facilitate timely prescription and support physical and psychological adjustment.

  • Parents’ perceptions of power wheelchair prescription for children with a Neuromuscular Disorder: a scoping review
    'Informa UK Limited', 2019
    Co-Authors: Sarahgrace Paguinto, Nadine A Kasparian, Bray P, Farrar M
    Abstract:

    © 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group. Purpose: To conduct a scoping review of the published evidence on parents’ perceptions of power wheelchair prescription for children with a Neuromuscular Disorder and clinicians’ influence on timely wheelchair implementation. Method: Nine electronic databases and reference lists of all retrieved full-text articles were searched up to March 2017. Eligibility criteria included (1) at least one child participant with a Neuromuscular Disorder, (2) power wheelchair as an intervention, and (3) qualitative, quantitative or mixed methods parent-reported outcomes related to power wheelchair equipment. Results: None of the 67 eligible studies examined parental perceptions of wheelchair prescription as a primary aim, and only 10 studies included children with a Neuromuscular Disorder. Parents reported their own emotional responses including grief and loss, emphasis on their child’s walking and lack of accessibility as key barriers to power wheelchair prescription. Clinicians’ perspectives on walking and powered mobility influenced parental decision-making regarding power wheelchair use for their child. Conclusion: Parents’ experiences of initial wheelchair prescription have not been explored in existing literature. Clinicians’ understanding of the benefits of power wheelchair equipment, particularly in the context of progression of Neuromuscular Disorders, is critical to facilitating timely wheelchair prescription with children. Condition-specific evidence is urgently needed to inform and support multidisciplinary management of children and their families.Implications for Rehabilitation It is important that rehabilitation professionals recognize parental barriers to initial power wheelchair prescription, such as strong emotional responses, an emphasis on their child’s walking and lack of access. Clinicians’ perspectives on walking and powered mobility may influence parental decision-making regarding engagement in power wheelchair prescription and rehabilitation. It is critical that clinicians are aware of and actively educate families regarding the benefits of powered mobility to facilitate timely prescription and support physical and psychological adjustment

Vladislav S Baranov - One of the best experts on this subject based on the ideXlab platform.

  • genetic and expression studies of smn2 gene in russian patients with spinal muscular atrophy type ii and iii
    BMC Medical Genetics, 2011
    Co-Authors: Galina Y Zheleznyakova, Viktor G Vakharlovsky, Mathias Raskandersen, Rohit A Chavan, Anna Egorova, Helgi B Schioth, A. V. Kiselev, Vladislav S Baranov
    Abstract:

    Background Spinal muscular atrophy (SMA type I, II and III) is an autosomal recessive Neuromuscular Disorder caused by mutations in the survival motor neuron gene (SMN1). SMN2 is a centromeric copy gene that has been characterized as a major modifier of SMA severity. SMA type I patients have one or two SMN2 copies while most SMA type II patients carry three SMN2 copies and SMA III patients have three or four SMN2 copies. The SMN1 gene produces a full-length transcript (FL-SMN) while SMN2 is only able to produce a small portion of the FL-SMN because of a splice mutation which results in the production of abnormal SMNΔ7 mRNA.

Yasser Salem - One of the best experts on this subject based on the ideXlab platform.

  • Spinal Muscular Atrophy
    Neuromuscular Disorders, 2012
    Co-Authors: Yasser Salem
    Abstract:

    Spinal muscular atrophy (SMA) is a Neuromuscular Disorder characterized by degeneration of alpha motor neurons resulting in hypotonia, progressive muscular weakness and atrophy.30 Spinal muscular atrophy is one of the leading hereditary causes of infant mortality,31 it comprises the second most common fatal progressive diseases after cystic fibrosis.28 Spinal muscular atrophy is the most common Neuromuscular disease in childhood after Duchenne muscular dystrophy with an estimated incidence of 1 per 5,000 to 10,000 live births.4,11